Amgen to buy Horizon Therapeutics for $27.8 billion
Amgen has today agreed to buy Dublin headquartered Horizon Therapeutics in a deal valued at $27.8 billion, fortifying its rare diseases portfolio amid pressure on its top-selling products and marking the biggest buyout in the sector this year.
Business
• 21 Dec 22
